NBIX vs PFE
Neurocrine Biosciences vs Pfizer Inc. — AI-powered side-by-side comparison
| Metric | NBIX | PFE |
|---|---|---|
| AI Score | 66 | 61 |
| Price | $175.67 | $24.55 |
| P/E Ratio | 26.20× | 18.73× |
| ROE | 0.1% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 1.0% | 0.7% |
| Debt / Equity | 0.12× | 0.72× |
| Dividend Yield | 0.0% | 0.1% |
| RSI (14) | 56.8 | 45.7 |
| Beta | 0.386 | 0.307 |
| Expected Upside | — | +6.1% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
NBIX Full Analysis
PFE Full Analysis